ArticleFrontiers in aging neuroscience2025
Moderating effect of APOE ε4 on the association of sleep disturbance and amyloid-β pathology among cognitively normal older adults.
Article in Frontiers in aging neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Depression severity and sleep efficiency's associations with amyloid burden are additive but dependent on underlying genetic risk in late life depression.Alzheimer's & dementia (Amsterdam, Netherlands)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Sleep-wake rhythms are critical for the development of Alzheimer's disease (AD). However, the relationship of sleep disturbance, APOE ε4, and amyloid-β (Aβ) accumulation remains unclear. Thus, this study investigated the potential role of APOE ε4 allele in the association between sleep disturbance and brain Aβ burden among cognitively normal (CN) older adults. Methods: In this cross-sectional study, data were obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNl) Database. The sample consisted of CN individuals aged between 55 and 90 years with Aβ positron emission tomography scan, APOE genotype, and sleep assessment using the Neuropsychiatric Inventory. Results: The study included 1,000 CN participants, including 134 individuals with sleep disturbances and 306 APOE ε4 carriers (APOE ε4+). After adjusting for sex, age, years of education, and marital status, sleep disturbance was not associated with a higher Aβ burden among participants. However, a significant interaction between sleep disturbance and APOE ε4 on regional standardized uptake value ratios was observed, such as in the left hippocampus. Subgroup analysis revealed that sleep disturbance could affect the AD-sensitive brain regions in the APOE ε4 + group. Furthermore, the subjective severity of sleep disturbance was linearly associated with a more significant Aβ brain burden in the APOE ε4 + group. Conclusion: This study demonstrated that CN individuals with both APOE ε4 + status and sleep disturbance exhibited greater Aβ burden. Understanding the relationship between sleep and Aβ in CN older adults may inform sleep interventions that could reduce early Aβ accumulation and delay the onset of cognitive dysfunction associated with early AD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.